<HashMap><database>biostudies-literature</database><scores/><additional><submitter>O'Brien TF</submitter><funding>NIAID NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>597-609</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4785102</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(3)</volume><pubmed_abstract>Invariant natural killer T (iNKT) cells produce cytokines interleukin-4 (IL-4) and IL-13 during type-2 inflammatory responses. However, the nature in which iNKT cells acquire type-2 cytokine competency and the precise contribution of iNKT cell-derived IL-4 and IL-13 in vivo remains unclear. Using IL-13-reporter mice to fate-map cytokine-expressing cells in vivo, this study reveals that thymic iNKT cells express IL-13 early during development, and this IL-13-expressing intermediate gives rise to mature iNKT1, iNKT2, and iNKT17 subsets. IL-4 and IL-13 reporter mice also reveal that effector iNKT2 cells produce IL-4 but little IL-13 in settings of type-2 inflammation. The preferential production of IL-4 over IL-13 in iNKT2 cells results in part from their reduced GATA-3 expression. In summary, this work helps integrate current models of iNKT cell development, and further establishes non-coordinate production of IL-4 and IL-13 as the predominant pattern of type-2 cytokine expression among innate cells in vivo.</pubmed_abstract><journal>Mucosal immunology</journal><pubmed_title>Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation.</pubmed_title><pmcid>PMC4785102</pmcid><funding_grant_id>T32 GM007184</funding_grant_id><funding_grant_id>R01 AI119004</funding_grant_id><funding_grant_id>T32 AI052077</funding_grant_id><pubmed_authors>Abraham S</pubmed_authors><pubmed_authors>O'Brien TF</pubmed_authors><pubmed_authors>Bao K</pubmed_authors><pubmed_authors>Dell'Aringa M</pubmed_authors><pubmed_authors>Reinhardt RL</pubmed_authors><pubmed_authors>Ang WX</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation.</name><description>Invariant natural killer T (iNKT) cells produce cytokines interleukin-4 (IL-4) and IL-13 during type-2 inflammatory responses. However, the nature in which iNKT cells acquire type-2 cytokine competency and the precise contribution of iNKT cell-derived IL-4 and IL-13 in vivo remains unclear. Using IL-13-reporter mice to fate-map cytokine-expressing cells in vivo, this study reveals that thymic iNKT cells express IL-13 early during development, and this IL-13-expressing intermediate gives rise to mature iNKT1, iNKT2, and iNKT17 subsets. IL-4 and IL-13 reporter mice also reveal that effector iNKT2 cells produce IL-4 but little IL-13 in settings of type-2 inflammation. The preferential production of IL-4 over IL-13 in iNKT2 cells results in part from their reduced GATA-3 expression. In summary, this work helps integrate current models of iNKT cell development, and further establishes non-coordinate production of IL-4 and IL-13 as the predominant pattern of type-2 cytokine expression among innate cells in vivo.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 May</publication><modification>2026-05-29T20:39:22.875Z</modification><creation>2019-03-27T02:10:46Z</creation></dates><accession>S-EPMC4785102</accession><cross_references><pubmed>26349658</pubmed><doi>10.1038/mi.2015.78</doi></cross_references></HashMap>